Ecstasy-for-Medicine Advocate Raises $100 Million
Updated Jan. 5, 2024 8:54 am ETThe Multidisciplinary Association for Psychedelic Studies, a nonprofit leader in the pharmaceutical psychedelics industry, ...
Friday, September 12, 2025
Tag: Biotechnology Services
Gene Editing Will Change Medicine—and Maybe Health Investing Too
It usually takes time for scientific discoveries in the lab to make their way to the market.The groundbreaking gene-editing technology ...
‘Guided Missile Drugs’ Could Be Big Pharma’s Secret Weapon
Merck and Pfizer are the latest big pharma companies to invest in this booming area.
Amgen Could Get a Piece of the Obesity Market
Amgen has a couple of shots on goal to break into one of the biggest markets the pharmaceutical industry has ...
WSJ News Exclusive | The Hedge Fund That Made a Killing Betting Against Lina Khan
Pentwater Capital predicted that FTC efforts to block big deals would fail.
VinFast, Arm and Other Index Orphans Miss Out on Billions From Passive Investors
VinFast, the Vietnamese electric-vehicle maker, and Arm, a British chip designer, are caught in a weird limbo thanks to their ...
Looking for an Alternative to ESG Investing? Here’s One Possibility
As investors question the validity of ESG ratings, some are looking to public-benefit corporations instead.
Biogen’s New Boss Is Delivering, but Stock Isn’t Pricing It in Yet
The decision to buy Reata signals a new era under CEO Chris Viehbacher, and Wall Street’s skepticism presents an opportunity.
Biotech Stocks Join AI-Fueled Rally
Shares of Recursion Pharmaceuticals, Schrodinger and others that are implementing AI are surging.
A Surprising Beneficiary of New Alzheimer’s Drugs: GE HealthCare
Biogen, Eli Lilly drugs will expand the imaging market for companies in the diagnostics space.
EDITOR'S PICK
EP NEWSROOM
© 2025 Edinburg Post or its affiliated companies.